PGx News

  • Fri, April 02, 2021 8:08 AM | Anonymous

    Here’s the call for the next special issue of CPT on real world evidence (July 15 deadline):https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/26736/Real-World-Evidence

  • Sun, December 13, 2020 2:43 PM | Anonymous

    Deadline: January 01, 2021
    Link

  • Sun, December 13, 2020 2:41 PM | Anonymous

    Deadline: Feb 02, 2021
    PGx of Adverse Drug Reactions
    Link

  • Sun, December 13, 2020 2:38 PM | Anonymous

    Due date: April 01, 2021
    Special Issue of CPT: Pharmacogenetics & Pharmacogenomics
    Link

  • Sun, December 06, 2020 2:42 PM | Anonymous

    Charlie Paulding, PhD, representing PGRN, will be a speaker at the "Polygenic Risk Scores: Current Status and Future Utility" virtual conference being held Wed Feb 17.  Information

  • Sun, December 06, 2020 2:37 PM | Anonymous

    Kathy Giacomini, President of PGRN, will be a Key Note Speaker at the World Congress of Basic & Clinical Pharmacology - WCP 2022 being held in Glasgow, Scotland, July 17-22, 2022. For information: http://wcp2022.org

  • Sun, December 06, 2020 2:34 PM | Anonymous

    We are proud to announce that PGRN has entered into an agreement with ASCPT to publish at least 2 educational tutorials, White Papers or submissions for a Themed Issue. Kathy Giacomini will Chair the PGRN Journal Committee.

  • Mon, November 02, 2020 8:30 AM | Anonymous

    "Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies"

    https://www.futuremedicine.com/doi/10.2217/pgs-2020-0056

    "Evaluating the current level of pharmacists’ pharmacogenomics knowledge and its impact on pharmacogenomics implementation"

    https://www.futuremedicine.com/doi/10.2217/pgs-2020-0076

  • Mon, September 28, 2020 10:58 AM | Anonymous

    The reporting guideline for pharmacogenetic studies (STROPS) has recently been published in PLOS Med.
    https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003344

  • Wed, July 01, 2020 12:24 AM | Sook Wah Yee (Administrator)

    After 20 years of National Institute of Health funding, the Pharmacogenomics Research Network, PGRN, is now independent scientific society on July 1st, 2020.  Thank you for your membership support to establish the new PGRN! The transition is complete, and we have exceeded our membership goals and are off to a great start!

    The PGRN Officers and Councilors have a lot planned for the coming months. The mission of the Pharmacogenomics Research Network, henceforth referred to as the “Network” is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects.  This will be accomplished by: 1) providing a forum to advance, promote, support, encourage and facilitate communication among researchers, educators and practitioners in pharmacogenomics and related sciences through scientific meetings, seminars, publications and related activities; 2) advancing and promoting research in pharmacogenomics; and 3) providing awareness of the national and international importance of pharmacogenomics.

    For PGRN members, please don’t forget to join us on July 17 at 11 AM Eastern Time for the inaugural Research In Progress (RIPS) webinar by Alan Shuldiner, MD. Dr. Shuldiner will speak on "Building bridges between industry, academia, health care systems and communities to advance Precision Medicine". A schedule of upcoming RIPS webinars can be found here. If you are interested in joining the PGRN, you can become a member at www.pgrn.org.




Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software